A randomized clinical trial of methadone maintenance for prisoners: results at 1-month post-release
- PMID: 17628351
- PMCID: PMC2423344
- DOI: 10.1016/j.drugalcdep.2007.05.022
A randomized clinical trial of methadone maintenance for prisoners: results at 1-month post-release
Abstract
Background: Despite its effectiveness, methadone maintenance is rarely provided in American correctional facilities. This study is the first randomized clinical trial in the US to examine the effectiveness of methadone maintenance treatment provided to prisoners with pre-incarceration heroin addiction.
Methods: A three-group randomized controlled trial was conducted between September 2003 and June 2005. Two hundred eleven Baltimore pre-release inmates who were heroin dependent during the year prior to incarceration were enrolled in this study. Participants were randomly assigned to the following: counseling only: counseling in prison, with passive referral to treatment upon release (n=70); counseling+transfer: counseling in prison with transfer to methadone maintenance treatment upon release (n=70); and counseling+methadone: methadone maintenance and counseling in prison, continued in a community-based methadone maintenance program upon release (n=71).
Results: Two hundred participants were located for follow-up interviews and included in the current analysis. The percentages of participants in each condition that entered community-based treatment were, respectively, counseling only 7.8%, counseling+transfer 50.0%, and counseling+methadone 68.6%, p<.05. All pairwise comparisons were statistically significant (all ps<.05). The percentage of participants in each condition that tested positive for opioids at 1-month post-release were, respectively, counseling only 62.9%, counseling+transfer 41.0%, and counseling+methadone 27.6%, p<.05, with the counseling only group significantly more likely to test positive than the counseling+methadone group.
Conclusions: Methadone maintenance initiated prior to or immediately after release from prison appears to have beneficial short-term impact on community treatment entry and heroin use. This intervention may be able to fill an urgent treatment need for prisoners with heroin addiction histories.
Conflict of interest statement
Similar articles
-
A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release.Addiction. 2008 Aug;103(8):1333-42. doi: 10.1111/j.1360-0443.2008.002238.x. Addiction. 2008. PMID: 18855822 Free PMC article. Clinical Trial.
-
A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease.J Subst Abuse Treat. 2009 Oct;37(3):277-85. doi: 10.1016/j.jsat.2009.03.002. Epub 2009 Mar 31. J Subst Abuse Treat. 2009. PMID: 19339140 Free PMC article. Clinical Trial.
-
A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release.Drug Alcohol Depend. 2017 Mar 1;172:34-42. doi: 10.1016/j.drugalcdep.2016.11.037. Epub 2017 Jan 11. Drug Alcohol Depend. 2017. PMID: 28107680 Free PMC article. Clinical Trial.
-
A randomized controlled trial of interim methadone maintenance.Arch Gen Psychiatry. 2006 Jan;63(1):102-9. doi: 10.1001/archpsyc.63.1.102. Arch Gen Psychiatry. 2006. PMID: 16389204 Clinical Trial.
-
Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.J Subst Abuse Treat. 2006 Jul;31(1):3-7. doi: 10.1016/j.jsat.2006.03.007. J Subst Abuse Treat. 2006. PMID: 16814005 Review.
Cited by
-
Opioid-specific medication-assisted therapy and its impact on criminal justice and overdose outcomes.Campbell Syst Rev. 2022 Jan 7;18(1):e1215. doi: 10.1002/cl2.1215. eCollection 2022 Mar. Campbell Syst Rev. 2022. PMID: 36913194 Free PMC article.
-
Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder?J Subst Abuse Treat. 2018 Feb;85:61-65. doi: 10.1016/j.jsat.2017.01.018. Epub 2017 Feb 22. J Subst Abuse Treat. 2018. PMID: 28236511 Free PMC article. Clinical Trial.
-
Postprison release HIV-risk behaviors in a randomized trial of methadone treatment for prisoners.Am J Addict. 2012 Sep-Oct;21(5):476-87. doi: 10.1111/j.1521-0391.2012.00250.x. Am J Addict. 2012. PMID: 22882399 Free PMC article. Clinical Trial.
-
Budget impact tool for the incorporation of medications for opioid use disorder into jail/prison facilities.J Subst Use Addict Treat. 2023 Mar;146:208943. doi: 10.1016/j.josat.2022.208943. Epub 2023 Jan 26. J Subst Use Addict Treat. 2023. PMID: 36880906 Free PMC article.
-
Factors associated with methadone maintenance therapy discontinuation among people who inject drugs.J Subst Abuse Treat. 2018 Nov;94:41-46. doi: 10.1016/j.jsat.2018.08.009. Epub 2018 Aug 23. J Subst Abuse Treat. 2018. PMID: 30243416 Free PMC article.
References
-
- Agresti A. Categorical Data Analysis. New York: Wiley; 1990.
-
- American Association for the Treatment of Opioid Dependence. AATOD’s Five-Year Plan for Methadone Treatment in the United States. 2001. Retrieved August 16, 2004 from http://www.aatod.org/factsheet4_print.htm.
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: Author; 1994.
-
- Anglin MD. The efficacy of civil commitment in treating narcotic addiction. National Institute on Drug Abuse Research Monograph. 1988;86:8–34. - PubMed
-
- Ball JC, Ross A. The Effectiveness of Methadone Maintenance Treatment: Patients, programs, services, and outcomes. New York, NY: Springer; 1991.